Thomas E. Grys
6Patents
1h-index
7Co-inventors
40Inventor score
Filing activity: Feb 25, 2004 → May 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7214479B2 | E. coli O157:H7 C1-INH-binding protein and methods of use | Human Necessities | 1 | Expired |
| US7264922B2 | Method of reducing complement - mediated disruption of cells | Human Necessities | 1 | Expired |
| US11045451B2 | Antigen-driven detection and treatment of coccidioidomycosis | Physics | 1 | Active |
| US7704718B2 | Method of reducing the viscosity of mucus | Human Necessities | 0 | Active |
| US12306175B2 | Biomarkers for detection and treatment assessment of infectious diseases and disorders | Physics | 0 | Active |
| US12053455B2 | Antigen-driven detection and treatment of coccidioidomycosis | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.